# Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid Tumors

> **NCT01980667** · PHASE1 · COMPLETED · sponsor: **PharmaMar** · enrollment: 41 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** lurbinectedin (PM01183)
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01980667
- **Lead sponsor:** PharmaMar
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-30
- **Primary completion:** 2017-01-05
- **Final completion:** 2017-01-05
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2017-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01980667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01980667, "Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT01980667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*